The phrase "absorption abnormalities" is correct and usable in written English.
It can be used in medical or scientific contexts to describe issues related to the body's ability to absorb nutrients or substances.
Example: "The patient was diagnosed with absorption abnormalities, which led to significant nutritional deficiencies."
Alternatives: "absorption issues" or "absorption disorders".
Patients were excluded from the study if they presented with concomitant pathologies that could interfere in the evaluation of BTM, such as bone metabolic disorders, Paget's disease of bone, hyperparathyroidism, thyroid abnormalities, abnormal intestinal absorption, or hepatic or renal dysfunction.
Patients were excluded from the study if they presented with concomitant pathologies that could interfere in the evaluation of biochemical markers of bone turnover such as bone metabolic disorders, Paget's disease of bone, hyperparathyroidism, thyroid abnormalities, abnormal intestinal absorption or hepatic or renal alterations.
To assess whether an abnormality in cholesterol absorption or synthesis may be associated with hypocholesterolemia in patients with single ventricle anatomy following Fontan palliation.
Malabsorption test, any of a group of noninvasive medical procedures used to diagnose abnormalities associated with poor absorption of nutrients.
This hypothesis has received little attention so far, although numerous small intestinal abnormalities possibly interfering with absorption are known to occur in intensive care patients.
The presence of TA and a TOF may interfere with fetal swallowing because in 39% of the cases with polyhydramnion, no other congenital abnormalities interfering with fetal swallowing and/or absorption of fluid, such as gastrointestinal obstruction, were present.
Intestinal failure is the inability to independently maintain nutrition via enteral absorption and has many causes, including genetic and metabolic abnormalities.
Gastrointestinal abnormalities that would interfere with intake or absorption of the study drug were also treated as criteria for patient exclusion.
In breast tumor diagnosis scenarios, the vascular-abnormality in cancerous regions often provides an absorption contrast of about 1.5-2.5 1.5-2.5μ a (T ) ≃ 0.004 − 0.009 mm − 1, depending on the malignancy stage and the wavelength.e
